Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Elixxer Ltd. V.QBA


Primary Symbol: V.ELXR

Elixxer Ltd is a Canada based company engaged in growing and producing medical-grade cannabis. It focuses on making investments in Nutraceuticals, Cosmetics, Pharma, and Cultivation and Extraction sectors.


TSXV:ELXR - Post by User

Comment by keeniinvestoron Aug 24, 2018 1:54pm
101 Views
Post# 28513753

RE:RE:RE:RE:RE:LG IS THE FIRST IN AUSTRALIA LIKE WEED IN CANADA

RE:RE:RE:RE:RE:LG IS THE FIRST IN AUSTRALIA LIKE WEED IN CANADA

Yes .... I guess these NRs make it abundantly clear that it is 14.45%


LGC to increase Little Green Pharma interest to 14.99%

 

2018-01-22 08:51 PT - News Release

 

Mr. John McMullen reports

LGC CAPITAL TO INCREASE STRATEGIC INTEREST IN AUSTRALIAN MEDICAL CANNABIS COMPANY - LITTLE GREEN PHARMA

LGC Capital Ltd. has entered into a binding term sheet with licensed Australian medical cannabis company Habi Pharma Pty. Ltd. of Perth, Australia, doing business as Little Green Pharma, to increase LGC's strategic interest in Little Green Pharma from 11.91 per cent to 14.99 per cent.

 

 

LGC increases Little Green Pharma stake to 14.99%

 

2018-02-15 10:30 PT - News Release

 

Mr. John McMullen reports

LGC CAPITAL INCREASES STRATEGIC INTEREST IN AUSTRALIAN MEDICAL CANNABIS COMPANY - LITTLE GREEN PHARMA

On Feb. 14, 2018, LGC Capital Ltd. completed its previously announced transaction with licensed Australian medical cannabis company Habi Pharma Pty. Ltd. of Perth, Australia, doing business as Little Green Pharma, whereby LGC increased its strategic interest in Little Green Pharma to 14.99 per cent from 11.91 per cent.

 

<< Previous
Bullboard Posts
Next >>